These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 31554817)

  • 1. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.
    Guerreiro Stucklin AS; Ryall S; Fukuoka K; Zapotocky M; Lassaletta A; Li C; Bridge T; Kim B; Arnoldo A; Kowalski PE; Zhong Y; Johnson M; Li C; Ramani AK; Siddaway R; Nobre LF; de Antonellis P; Dunham C; Cheng S; Boué DR; Finlay JL; Coven SL; de Prada I; Perez-Somarriba M; Faria CC; Grotzer MA; Rushing E; Sumerauer D; Zamecnik J; Krskova L; Garcia Ariza M; Cruz O; Morales La Madrid A; Solano P; Terashima K; Nakano Y; Ichimura K; Nagane M; Sakamoto H; Gil-da-Costa MJ; Silva R; Johnston DL; Michaud J; Wilson B; van Landeghem FKH; Oviedo A; McNeely PD; Crooks B; Fried I; Zhukova N; Hansford JR; Nageswararao A; Garzia L; Shago M; Brudno M; Irwin MS; Bartels U; Ramaswamy V; Bouffet E; Taylor MD; Tabori U; Hawkins C
    Nat Commun; 2019 Sep; 10(1):4343. PubMed ID: 31554817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.
    Pietrantonio F; Di Nicolantonio F; Schrock AB; Lee J; Tejpar S; Sartore-Bianchi A; Hechtman JF; Christiansen J; Novara L; Tebbutt N; Fucà G; Antoniotti C; Kim ST; Murphy D; Berenato R; Morano F; Sun J; Min B; Stephens PJ; Chen M; Lazzari L; Miller VA; Shoemaker R; Amatu A; Milione M; Ross JS; Siena S; Bardelli A; Ali SM; Falcone A; de Braud F; Cremolini C
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29370427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tyrosine kinase receptor gene fusion: A series of four cases of infantile-type hemispheric glioma].
    Sourty B; Basset L; Michalak S; Colin E; Zidane-Marinnes M; Delion M; de Carli E; Rousseau A
    Ann Pathol; 2023 Nov; 43(6):462-474. PubMed ID: 37635016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crizotinib targets in glioblastoma stem cells.
    Junca A; Villalva C; Tachon G; Rivet P; Cortes U; Guilloteau K; Balbous A; Godet J; Wager M; Karayan-Tapon L
    Cancer Med; 2017 Nov; 6(11):2625-2634. PubMed ID: 28960893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusing the Genetic Landscape of Infantile High-Grade Gliomas.
    Szulzewsky F; Cimino PJ
    Cancer Discov; 2020 Jul; 10(7):904-906. PubMed ID: 32611733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing.
    Jurmeister P; Lenze D; Berg E; Mende S; Schäper F; Kellner U; Herbst H; Sers C; Budczies J; Dietel M; Hummel M; von Laffert M
    Lung Cancer; 2015 Feb; 87(2):122-9. PubMed ID: 25534130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.
    Meredith DM; Cooley LD; Dubuc A; Morrissette J; Sussman RT; Nasrallah MP; Rathbun P; Yap KL; Wadhwani N; Bao L; Wolff DJ; Ida C; Sukhanova M; Horbinski C; Jennings LJ; Farooqi M; Gener M; Ginn K; Kam KL; Sasaki K; Kanagal-Shamanna R; Alexandrescu S; Brat D; Lu X
    Mod Pathol; 2023 Nov; 36(11):100294. PubMed ID: 37532182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal Growth Factor Receptor (EGFR) Mutations and Anaplastic Lymphoma Kinase/Oncogene or C-Ros Oncogene 1 (ALK/ROS1) Fusions Inflict Non-Small Cell Lung Cancer (NSCLC) Female Patients Older Than 60 Years of Age.
    Ke L; Xu M; Jiang X; Sun X
    Med Sci Monit; 2018 Dec; 24():9364-9369. PubMed ID: 30580372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma.
    Nakano Y; Tomiyama A; Kohno T; Yoshida A; Yamasaki K; Ozawa T; Fukuoka K; Fukushima H; Inoue T; Hara J; Sakamoto H; Ichimura K
    Brain Tumor Pathol; 2019 Jan; 36(1):14-19. PubMed ID: 30350109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis-like neural tumor pattern.
    Kao YC; Suurmeijer AJH; Argani P; Dickson BC; Zhang L; Sung YS; Agaram NP; Fletcher CDM; Antonescu CR
    Genes Chromosomes Cancer; 2020 Oct; 59(10):575-583. PubMed ID: 32506523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infant-Type Hemispheric Glioma in a Chinese Girl: A Newly Defined Entity.
    Fang Y; Wang YZ; Wei X; Li SM; Chen L
    Fetal Pediatr Pathol; 2023 Feb; 42(1):114-122. PubMed ID: 35404193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pediatric Glioma].
    Terashima K; Ogiwara H
    No Shinkei Geka; 2021 May; 49(3):640-646. PubMed ID: 34092570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an update.
    Lassaletta A; Zapotocky M; Bouffet E; Hawkins C; Tabori U
    Childs Nerv Syst; 2016 Oct; 32(10):1789-97. PubMed ID: 27659822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic and epigenomic re-categorization of congenital glioblastoma and desmoplastic infantile ganglioglioma.
    Gilani A; Siddiq Z; Kissell E; Kasson J; Kleinschmidt-DeMasters BK
    Childs Nerv Syst; 2023 Jul; 39(7):1861-1868. PubMed ID: 36707425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion.
    Furugaki K; Mochizuki M; Kohno M; Shu S; Harada N; Yoshimura Y
    BMC Cancer; 2019 Apr; 19(1):301. PubMed ID: 30943926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
    Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
    Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive evaluation of the test for 5'-/3'-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer.
    Mitiushkina NV; Romanko AA; Preobrazhenskaya EV; Tiurin VI; Ermachenkova TI; Martianov AS; Mulkidjan RS; Sokolova TN; Kholmatov MM; Bizin IV; Ivantsov AO; Yatsuk OS; Zaitseva OA; Iyevleva AG; Kuligina ES; Imyanitov EN
    Cancer Med; 2022 Sep; 11(17):3226-3237. PubMed ID: 35322575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features of 54 cases of lung adenocarcinomas with c-ROS oncogene 1 fusion].
    Cao H; Zheng J; Zhao J; Guo XJ; Zhou JY; Ding W; Zhou JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):120-125. PubMed ID: 32062881
    [No Abstract]   [Full Text] [Related]  

  • 19. GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
    Richardson TE; Tang K; Vasudevaraja V; Serrano J; William CM; Mirchia K; Pierson CR; Leonard JR; AbdelBaki MS; Schieffer KM; Cottrell CE; Tovar-Spinoza Z; Comito MA; Boué DR; Jour G; Snuderl M
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1089-1099. PubMed ID: 31626289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma.
    Kim HR; Lim SM; Kim HJ; Hwang SK; Park JK; Shin E; Bae MK; Ou SH; Wang J; Jewell SS; Kang DR; Soo RA; Haack H; Kim JH; Shim HS; Cho BC
    Ann Oncol; 2013 Sep; 24(9):2364-70. PubMed ID: 23788756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.